ACRS vs LVS · rev $3.6M vs P/E 28, rev $6.74B
Aclaris Therapeutics Inc (ACRS) versus Las Vegas Sands Corp (LVS) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported LVS revenue for 2026-06-30 was $6.74B. Net income was $913.0M. Revenue was up 88.0% from 2026-03-31 to 2026-06-30. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
ACRS currently screens at market cap $615.9M. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Not investment advice. Open the ACRS and LVS stock pages for the full models.
Not investment advice.